Abstract White matter hyperintensities are radiological abnormalities reflecting cerebrovascular dysfunction detectable using MRI. White matter hyperintensities are often present in individuals at the later stages of the lifespan and in prodromal stages in the Alzheimer’s disease spectrum. Tissue alterations underlying white matter hyperintensities may include demyelination, inflammation and oedema, but these are highly variable by neuroanatomical location and between individuals. There is a crucial need to characterize these white matter hyperintensity tissue alterations in vivo to improve prognosis and, potentially, treatment outcomes. How different MRI measure(s) of tissue microstructure capture clinically-relevant white matter hyperintensity tissue damage is currently unknown. Here, we compared six MRI signal measures sampled within white matter hyperintensities and their associations with multiple clinically-relevant outcomes, consisting of global and cortical brain morphometry, cognitive function, diagnostic and demographic differences and cardiovascular risk factors. We used cross-sectional data from 118 participants: healthy controls (n = 30), individuals at high risk for Alzheimer’s disease due to familial history (n = 47), mild cognitive impairment (n = 32) and clinical Alzheimer’s disease dementia (n = 9). We sampled the median signal within white matter hyperintensities on weighted MRI images [T1-weighted (T1w), T2-weighted (T2w), T1w/T2w ratio, fluid-attenuated inversion recovery (FLAIR)] as well as the relaxation times from quantitative T1 (qT1) and T2* (qT2*) images. qT2* and fluid-attenuated inversion recovery signals within white matter hyperintensities displayed different age- and disease-related trends compared to normal-appearing white matter signals, suggesting sensitivity to white matter hyperintensity-specific tissue deterioration. Further, white matter hyperintensity qT2*, particularly in periventricular and occipital white matter regions, was consistently associated with all types of clinically-relevant outcomes in both univariate and multivariate analyses and across two parcellation schemes. qT1 and fluid-attenuated inversion recovery measures showed consistent clinical relationships in multivariate but not univariate analyses, while T1w, T2w and T1w/T2w ratio measures were not consistently associated with clinical variables. We observed that the qT2* signal was sensitive to clinically-relevant microstructural tissue alterations specific to white matter hyperintensities. Our results suggest that combining volumetric and signal measures of white matter hyperintensity should be considered to fully characterize the severity of white matter hyperintensities in vivo. These findings may have implications in determining the reversibility of white matter hyperintensities and the potential efficacy of cardio- and cerebrovascular treatments.
Assessment of white matter hyperintensity severity using multimodal magnetic resonance imaging
O. Parent,A. Bussy,Gabriel A. Devenyi,Alyssa Dai,M. Costantino,Stephanie Tullo,Alyssa Salaciak,S. Bedford,Sarah Farzin,Marie-Lise Béland,Vanessa Valiquette,Sylvia Villeneuve,J. Poirier,C. Tardif,M. Dadar,Angela Tam,A. Labonté,Alexa Pichet Binette,A. Faubert,Axel Mathieu,C. Madjar,Charles Edouard Carrier,C. Dansereau,Christina Kazazian,C. Lepage,C. Picard,David Maillet,Diane Michaud,Doris Couture,D. Dea,Claudio Cuello,Alan N. Barkun,Alan Evans,B. Courcot,C. Tardif,Clément Debacker,Clifford R. Jack,David Fontaine,D. Knopman,Gerhard Multhaup,Jamie Near,J. Leoutsakos,Jean-Robert Maltais,Jason Brandt,J. Pruessner,John C Morris,J. C. Breitner,J. Poirier,Laksanun Cheewakriengkrai,Lisa-Marie Münter,Louis Collins,M. Chakravarty,Mark A. Sager,Marina Dauar-Tedeschi,Mark Eisenberg,Natasha Rajah,P. Aisen,P. Toussaint,P. Rosa-Neto,Pierre C. Bellec,P. Kostopoulos,Pierre Etienne,Pierre N. Tariot,P. Orban,R. Sperling,Rick Hoge,Ronald G Thomas,S. Gauthier,Suzanne Craft,Sylvia Villeneuve,T. Montine,V. Nair,Véronique Bohbot,Vinod Venugopalan,Vladimir S Fonov,Yasser Ituria-Medina,Z. Khachaturian,Eduard Teigner,Elena Anthal,E. Yu,Fabiola Ferdinand,Galina Pogossova,G. Mayrand,Guerda Duclair,Guylaine Gagné,Holly Newbold-Fox,Illana Leppert,Isabelle Vallée,Jacob W Vogel,J. Tremblay-Mercier,J. Frenette,J. Frappier,J. Kat,J. Miron,Karen Wan,Laura Mahar,Leopoldina Carmo,L. Théroux,M. Dadar,Marianne Dufour,Marie‐Élyse Lafaille‐Magnan,Melissa Appleby,M. Savard,Miranda Tuwaig,Mirela Petkova,Pierre Rioux,P. Meyer,Rana El-Khoury,R. Gordon,Renuka Giles,Samir Das,Seqian Wang,Shirin Tabrizi,S. Mathotaarachchi,Sylvie Dubuc,Tanya Lee,T. Beaudry,Valérie Gervais,Véronique Pagé,J. Gonneaud,Gülebru Ayranci,T. Pascoal,René Désautels,Fatiha Benbouhoud,Eunice Farah Saint-Fort,S. Verfaillie,Sarah Farzin,Alyssa Salaciak,Stephanie Tullo,Étienne Vachon-Presseau,Leslie-Ann Daoust,Theresa Köbe,N. Spreng,Melissa Mcsweeney,Nathalie I.V. Nilsson,Morteza Pishnamazi,C. Bedetti,Louise Hudon,Claudia Greco,J. Soucy,M. Chakravarty
Published 2023 in Brain Communications
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
Brain Communications
- Publication date
2023-10-19
- Fields of study
Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-92 of 92 references · Page 1 of 1
CITED BY
Showing 1-18 of 18 citing papers · Page 1 of 1